申请人:ALECTOS THERAPEUTICS INC.
公开号:US20220213058A1
公开(公告)日:2022-07-07
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.